Table 4 Platelet aggregation (%) at different time points
Treatment | Cohort | Dose, mg twice daily | Baseline | Day 8 | Day 15 |
|---|---|---|---|---|---|
Placebo | – | – | 61.50 (24.34) | 52.67 (23.84) | 68.17 (13.82) |
Active ingredients | 9 | 360 | 56.17 (31.56) | 68.83 (13.24) | 55.00 (15.19) |
Active ingredients | 10 | 720 | 63.50 (14.17) | 42.83 (13.91) | 58.00 (17.78) |
Active ingredients | 11 | 2160 | 77.00 (7.24) | 67.00 (16.78) | 72.83 (12.73) |
Repeated-measures analysis of variance | Group | F | 2.83 | Â | Â |
P value | 0.06 | Â | Â | ||
Time | F | 0.97 | Â | Â | |
P value | 0.36 | Â | Â | ||
Group*Time | F | 1.29 | Â | Â | |
P value | 0.3 | Â | Â |